Cargando…
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration
PEGylated lipids are one of the four constituents of lipid nanoparticle mRNA COVID-19 vaccines. Therefore, various concerns have been raised on the generation of anti-PEG antibodies and their potential role in inducing hypersensitivity reactions following vaccination or in reducing vaccine efficacy...
Autores principales: | Guerrini, Giuditta, Gioria, Sabrina, Sauer, Aisha V., Lucchesi, Simone, Montagnani, Francesca, Pastore, Gabiria, Ciabattini, Annalisa, Medaglini, Donata, Calzolai, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408675/ https://www.ncbi.nlm.nih.gov/pubmed/36012103 http://dx.doi.org/10.3390/ijms23168838 |
Ejemplares similares
-
Physicochemical Characterization Cascade of Nanoadjuvant–Antigen Systems for Improving Vaccines
por: Guerrini, Giuditta, et al.
Publicado: (2021) -
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity?
por: Pettini, Elena, et al.
Publicado: (2021) -
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses
por: Pettini, Elena, et al.
Publicado: (2022) -
Computational Analysis of Multiparametric Flow Cytometric Data to Dissect B Cell Subsets in Vaccine Studies
por: Lucchesi, Simone, et al.
Publicado: (2019) -
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?
por: Panza, Francesca, et al.
Publicado: (2023)